Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Liv Sagatun, Reidar Fossmark, Constantin S. Jianu, Gunnar Qvigstad, Ivar S. Nordrum, Patricia Mjønes & Helge L. Waldum. (2016) Follow-up of patients with ECL cell-derived tumours. Scandinavian Journal of Gastroenterology 51:11, pages 1398-1405.
Read now
Read now
Constantin S. Jianu, Reidar Fossmark, Unni Syversen, Øyvind Hauso, Vidar Fykse & Helge L. Waldum. (2011) Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids. Scandinavian Journal of Gastroenterology 46:4, pages 456-463.
Read now
Read now
Articles from other publishers (23)
Philipp Melhorn, Peter Mazal, Ladislaia Wolff, Elisabeth Kretschmer-Chott, Markus Raderer & Barbara Kiesewetter. (2024) From biology to clinical practice: antiproliferative effects of somatostatin analogs in neuroendocrine neoplasms. Therapeutic Advances in Medical Oncology 16.
Crossref
Crossref
Gabriel Antonio Roberto, Carolina Magalhães Britto Rodrigues, Renata D’Alpino Peixoto & Riad Naim Younes. (2020) Gastric neuroendocrine tumor: A practical literature review. World Journal of Gastrointestinal Oncology 12:8, pages 850-856.
Crossref
Crossref
Roberta Elisa Rossi, Pietro Invernizzi, Vincenzo Mazzaferro & Sara Massironi. (2020) Response and relapse rates after treatment with long‐acting somatostatin analogs in multifocal or recurrent type‐1 gastric carcinoids: A systematic review and meta‐analysis. United European Gastroenterology Journal 8:2, pages 140-147.
Crossref
Crossref
Liv Sagatun, Patricia Mjønes, Constantin S. Jianu, Malcolm Boyce, Hege L. Waldum & Reidar Fossmark. (2016) The gastrin receptor antagonist netazepide (YF476) in patients with type 1 gastric enterochromaffin-like cell neuroendocrine tumours: review of long-term treatment. European Journal of Gastroenterology & Hepatology 28:11, pages 1345-1352.
Crossref
Crossref
Davide Campana, Davide Ravizza, Piero Ferolla, Antongiulio Faggiano, Franco Grimaldi, Manuela Albertelli, Debora Berretti, Danilo Castellani, Giulia Cacciari, Nicola Fazio, Annamaria Colao, Diego Ferone & Paola Tomassetti. (2015) Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study. Endocrine 51:1, pages 131-139.
Crossref
Crossref
Sara Massironi, Alessandra Zilli, Ilaria Fanetti, Clorinda Ciafardini, Dario Conte & Maddalena Peracchi. (2015) Intermittent treatment of recurrent type-1 gastric carcinoids with somatostatin analogues in patients with chronic autoimmune atrophic gastritis. Digestive and Liver Disease 47:11, pages 978-983.
Crossref
Crossref
Mark Kidd, Bjorn Gustafsson & Irvin M. Modlin. (2013) Gastric Carcinoids (Neuroendocrine Neoplasms). Gastroenterology Clinics of North America 42:2, pages 381-397.
Crossref
Crossref
R. Fossmark, Ø. Sørdal, C. S. Jianu, G. Qvigstad, I. S. Nordrum, M. Boyce & H. L. Waldum. (2012) Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A. Alimentary Pharmacology & Therapeutics 36:11-12, pages 1067-1075.
Crossref
Crossref
Mark Kidd & Bjorn I. Gustafsson. (2012) Management of Gastric Carcinoids (Neuroendocrine Neoplasms). Current Gastroenterology Reports 14:6, pages 467-472.
Crossref
Crossref
Linda Zhang, Junko Ozao, Richard Warner & Celia Divino. (2011) Review of the Pathogenesis, Diagnosis, and Management of Type I Gastric Carcinoid Tumor. World Journal of Surgery 35:8, pages 1879-1886.
Crossref
Crossref
Chiara Tieppo, Corrado Betterle, Daniela Basso, Claudia Mescoli, Massimo Rugge, Chiara Martini, Valerio Zorzetto, Gemma Maddalo, Nora Cazzagon, Donato Nitti & Fabio Farinati. (2011) Gastric type I carcinoid: a pilot study with human G17DT immunogen vaccination. Cancer Immunology, Immunotherapy 60:7, pages 1057-1060.
Crossref
Crossref
M.B. Niederle & B. Niederle. (2011) Neuroendokrine Tumoren des MagensGastric neuroendocrine tumors. Der Chirurg 82:7, pages 574-582.
Crossref
Crossref
Ben Lawrence, Bjorn I. Gustafsson, Mark Kidd, Marianne Pavel, Bernhard Svejda & Irvin M. Modlin. (2011) The Clinical Relevance of Chromogranin A as a Biomarker for Gastroenteropancreatic Neuroendocrine Tumors. Endocrinology and Metabolism Clinics of North America 40:1, pages 111-134.
Crossref
Crossref
Ben Lawrence, Mark Kidd, Bernhard Svejda & Irvin Modlin. (2010) A Clinical Perspective on Gastric Neuroendocrine Neoplasia. Current Gastroenterology Reports 13:1, pages 101-109.
Crossref
Crossref
Hyo Keun JeonHyun-Soo Kim. (2011) Neuroendocrine Tumor in Upper Gastrointestinal Tract. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 11:2, pages 75.
Crossref
Crossref
M Kidd, Z-L Siddique, I. Drozdov, B.I. Gustafsson, R.L. Camp, J.W. Black, M. Boyce & I.M. Modlin. (2010) The CCK2 receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development. Regulatory Peptides 162:1-3, pages 52-60.
Crossref
Crossref
Mehnaaz Sultan Khuroo, Mohammad Sultan Khuroo & Naira Sultan Khuroo. (2010) Treatment of type I gastric neuroendocrine tumors with somatostatin analogs. Journal of Gastroenterology and Hepatology 25:3, pages 548-554.
Crossref
Crossref
Irvin M. Modlin, Mark Kidd, Maximillian V. Malfertheiner & Bjorn I. Gustafsson. 2009. The Biology of Gastric Cancers. The Biology of Gastric Cancers
185
216
.
Sylvain Manfredi, Mael Pagenault, Anne-Sophie de Lajarte-Thirouard & Jean-François Bretagne. (2007) Type 1 and 2 gastric carcinoid tumors: long-term follow-up of the efficacy of treatment with a slow-release somatostatin analogue. European Journal of Gastroenterology & Hepatology 19:11, pages 1021-1025.
Crossref
Crossref
M. Kidd, I.M. Modlin, J.W. Black, M. Boyce & M. Culler. (2007) A comparison of the effects of gastrin, somatostatin and dopamine receptor ligands on rat gastric enterochromaffin-like cell secretion and proliferation. Regulatory Peptides 143:1-3, pages 109-117.
Crossref
Crossref
Anikó Somogyi, Éva Ruzicska, Timea Varga, Károly Rácz & Géza Nagy. (2007) Development of silent gastric carcinoid in a type 1 diabetic patient with primer hypothyreosis. Orvosi Hetilap 148:35, pages 1667-1671.
Crossref
Crossref
M. D. BURKITT & D. M. PRITCHARD. (2006) Review article: pathogenesis and management of gastric carcinoid tumours. Alimentary Pharmacology & Therapeutics 24:9, pages 1305-1320.
Crossref
Crossref
P. Guillem. (2006) Réponse de l'auteur de l'article « Les tumeurs carcinoïdes de l'estomac ». Quelle place pour l'antrectomie ?. Annales de Chirurgie 131:4, pages 294.
Crossref
Crossref